So, we built a pharmacy to try to correct that, and then along the way, what we realized is we've actually got a pretty good asset here that is really good at getting medications from the manufacturer from the plant to the consumer quickly, efficiently and effectively
That is, compared to insulin, 57 and 30 patients would need to be treated with a GLP-1RA for a mean of 2.3 years to prevent one case of all-cause mortality and hospitalized hypoglycemia, respectively, which would cost US$54,851 and US$29,115 per case of all-cause mortality and hospitalized hypoglycemia prevented, respectively, from the payer perspective, and would save US$19,391 and US$10,293, respectively, from the healthcare sector perspective
Research shows GLP-1 therapies can help you lose between 8% and 21% of your body weightyet up to 40% of that loss can be lean mass
Express or implied claims that FDA approved, evaluated, or reviewed the compounded product for safety, effectiveness, or quality
Semaglutide does not just increase GLP-1 by 20 percent
Results compound over time